Adverse Effects of COVID-19 Vaccines Among Medical Students: A Study from Khyber Pakhtunkhwa
DOI:
https://doi.org/10.1996/pjcm.v29i4.813Keywords:
COVID-19, Vaccine, Side Effects, Medical Students, PakistanAbstract
Background: Vaccinations protect against disease in a variety of ways, but the process of developing immunity might result in side effects. Up till effective vaccines are widely distributed to the entire globe with fewer side effects, breakouts and disruptions to social and economic life are probably risks. Objective: To investigate the prevalence and seriousness of COVID-19 vaccine-related side effects among medical students. Methodology: This cross-sectional investigation was carried out at several Medical Colleges in Khyber Pakhtunkhwa. Between July 2021 and December 2021, data were gathered. Analysis was done on sociodemographic and clinical data, immunization schedules, and adverse effects. Result: The study had 470 vaccine recipients in total. Only 39.48% of those who received the COVID-19 vaccine reported experiencing any adverse reactions at all. The most often reported adverse effects were mild and lasted 1-3 days: injection-site pain, fever, headache, redness/swelling at the injection site, and tiredness. Most people who received the Sputaik V vaccine (approximately 42.97%) and those who received the Cansino vaccine (about 14.25%) experienced side effects. The ages of the respondents ranged from 18 to 25, with a mean age of 17.96±7.7 years. Additionally, it was noted that 253 (53.8%) females and 217 (46.17%) males had COVID-19 vaccinations. Conclusion: The vaccine's most frequent adverse effects were observed to be injection site pain, redness/swelling at the injection site, fever, headache, nausea, diarrhoea, cough, muscle pain, anxiety, less sleep, and more sleep. Additionally, there was a linear relationship between manifestations of adverse effects and a history of comorbidities.References
Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, Rovida F, Baldanti F, Marseglia GL. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Ped. 2020;174(9):882-9.
von Humboldt S, Low G, Leal I. Health service accessibility, mental health, and changes in behavior during the COVID-19 pandemic: a qualitative study of older adults. Int J Env Res Pub Health. 2022;19(7):4277.
Motamedi H, Ari MM, Dashtbin S, Fathollahi M, Hossainpour H, Alvandi A, Moradi J, Abiri R. An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages. Int Immun. 2021;96:107763.
Ayenigbara IO, Adegboro JS, Ayenigbara GO, Adeleke OR, Olofintuyi OO. The challenges to a successful COVID-19 vaccination programme in Africa. Germs. 2021;11(3):427.
Adams JG, Walls RM. Supporting the health care workforce during the COVID-19 global epidemic. JAMA. 2020;323(15):1439-40.
Casey N. College made them feel equal. The virus exposed how unequal their lives are. The New York Times. 2020;4.
Suzuki M, Yang S. Political economy of vaccine diplomacy: explaining varying strategies of China, India, and Russia’s COVID-19 vaccine diplomacy. Rev. Int. Political Econ. 2023;30(3):865-90.
Wambani J, Okoth P. Scope of SARS-CoV-2 variants, mutations, and vaccine technologies. Egypt J Intern Med. 2022 Dec;34(1):34.
El-Shitany NA, Harakeh S, Badr-Eldin SM, Bagher AM, Eid B, Almukadi H, Alghamdi BS, Alahmadi AA, Hassan NA, Sindi N, Alghamdi SA. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. Int J Gen Med. 2021 Apr 19:1389-401.
Calzetta L, Ritondo BL, Coppola A, Matera MG, Di Daniele N, Rogliani P. Factors influencing the efficacy of COVID-19 vaccines: a quantitative synthesis of phase III trials. Vaccines. 2021;9(4):341.
Bilawal Khaskheli M, Wang S, Hussain RY, Jahanzeb Butt M, Yan X, Majid S. Global law, policy, and governance for effective prevention and control of COVID-19: A comparative analysis of the law and policy of Pakistan, China, and Russia. Front Public Health. 2023 Jan 4;10:1035536.
Saleem Z, Godman B, Azhar F, Kalungia AC, Fadare J, Opanga S, Markovic-Pekovic V, Hoxha I, Saeed A, Al-Gethamy M, Haseeb A. Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): A narrative review and the implications. Expert Rev Anti Infect Ther. 2022;20(1):71-93.
Abdulla ZA, Al-Bashir SM, Al-Salih NS, Aldamen AA, Abdulazeez MZ. A summary of the SARS-CoV-2 vaccines and technologies available or under development. Pathogens. 2021;10(7):788.
Chaudhary JK, Yadav R, Chaudhary PK, Maurya A, Kant N, Rugaie OA, Haokip HR, Yadav D, Roshan R, Prasad R, Chatrath A. Insights into COVID-19 vaccine development based on immunogenic structural proteins of SARS-CoV-2, host immune responses, and herd immunity. Cells. 2021;10(11):2949.
Angeli F, Spanevello A, Reboldi G, Visca D, Verdecchia P. SARS-CoV-2 vaccines: Lights and shadows. Eur J Intern Med. 2021;88:1-8.
Oliver SE, Shimabukuro TT. Johnson & Johnson/Janssen COVID-19 vaccine and cerebral venous sinus thrombosis with thrombocytopenia–update for clinicians on early detection and treatment.
Siddique S, Ahmed S. COVID-19 Vaccines in Pakistan: Efficacy, adverse effects and availability. Journal of Islamabad Medical & Dental College. 2021 Jun 29;10(2):125-30.
Maital S, Barzani E. The global economic impact of COVID-19: A summary of research. Samuel Neaman Institute for National Policy Research. 2020;2020:1-2.
Elbarbary NS, Dos Santos TJ, de Beaufort C, Agwu JC, Calliari LE, Scaramuzza AE. COVID‐19 outbreak and pediatric diabetes: Perceptions of health care professionals worldwide. Pediatr Diabetes. 2020;21(7):1083-92.
Al Kaabi N, Zhang Y, Xia S, Yang Y, Al Qahtani MM, Abdulrazzaq N, Al Nusair M, Hassany M, Jawad JS, Abdalla J, Hussein SE. Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial. JAMA. 2021;326(1):35-45.
Hatmal MM, Al-Hatamleh MA, Olaimat AN, Hatmal M, Alhaj-Qasem DM, Olaimat TM, Mohamud R. Side effects and perceptions following COVID-19 vaccination in Jordan: a randomized, cross-sectional study implementing machine learning for predicting severity of side effects. Vaccines. 2021;9(6):556.
Abramo G, D’Angelo CA, Mele I. Impact of Covid-19 on research output by gender across countries. Scientometrics. 2022;127(12):6811-26.
Dinga JN, Sinda LK, Titanji VP. Assessment of vaccine hesitancy to a COVID-19 vaccine in Cameroonian adults and its global implication. Vaccines. 2021;9(2):175.
Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):160.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pakistan Journal of Chest Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
